Evolus, Inc. (EOLS)

USD 10.27

(7.65%)

Total Liabilities Summary of Evolus, Inc.

  • Evolus, Inc.'s latest annual total liabilities in 2023 was 209.68 Million USD , up 31.48% from previous year.
  • Evolus, Inc.'s latest quarterly total liabilities in 2024 Q1 was 207.73 Million USD , down -0.93% from previous quarter.
  • Evolus, Inc. reported annual total liabilities of 159.48 Million USD in 2022, down -9.18% from previous year.
  • Evolus, Inc. reported annual total liabilities of 175.6 Million USD in 2021, down -37.73% from previous year.
  • Evolus, Inc. reported quarterly total liabilities of 214.45 Million USD for 2024 Q2, up 3.24% from previous quarter.
  • Evolus, Inc. reported quarterly total liabilities of 187.33 Million USD for 2023 Q3, up 6.48% from previous quarter.

Annual Total Liabilities Chart of Evolus, Inc. (2023 - 2015)

Historical Annual Total Liabilities of Evolus, Inc. (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 209.68 Million USD 31.48%
2022 159.48 Million USD -9.18%
2021 175.6 Million USD -37.73%
2020 282.02 Million USD 75.19%
2019 160.98 Million USD 84.07%
2018 87.46 Million USD -61.6%
2017 227.77 Million USD 169.24%
2016 84.6 Million USD 22.08%
2015 69.29 Million USD 0.0%

Peer Total Liabilities Comparison of Evolus, Inc.

Name Total Liabilities Total Liabilities Difference
Collegium Pharmaceutical, Inc. 947.87 Million USD 77.878%
Embecta Corp. 2.03 Billion USD 89.702%
ANI Pharmaceuticals, Inc. 471.67 Million USD 55.544%
Dynavax Technologies Corporation 375.02 Million USD 44.087%
Esperion Therapeutics, Inc. 660.79 Million USD 68.267%
Pacira BioSciences, Inc. 704.25 Million USD 70.226%
PainReform Ltd. 2.69 Million USD -7692.159%
Aquestive Therapeutics, Inc. 163.9 Million USD -27.932%
Sunshine Biopharma, Inc. 6.13 Million USD -3315.32%
SCYNEXIS, Inc. 55.45 Million USD -278.155%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -2180.046%
Cosmos Health Inc. 30.25 Million USD -593.122%
Journey Medical Corporation 56.49 Million USD -271.134%
Sunshine Biopharma, Inc. 6.13 Million USD -3315.32%
Safety Shot Inc 3.89 Million USD -5287.58%
Alpha Teknova, Inc. 38.55 Million USD -443.921%
Intra-Cellular Therapies, Inc. 136.87 Million USD -53.2%
Bright Green Corporation 6.43 Million USD -3156.969%
Procaps Group, S.A. 462.06 Million USD 54.62%
Theratechnologies Inc. 98.63 Million USD -112.58%
Harrow Health, Inc. 241.75 Million USD 13.264%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -2294.781%
Biofrontera Inc. 23.13 Million USD -806.206%
DURECT Corporation 30.4 Million USD -589.624%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 56.984%
Cronos Group Inc. 43.73 Million USD -379.437%
OptiNose, Inc. 194.33 Million USD -7.9%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 74.346%
Kala Pharmaceuticals, Inc. 48.44 Million USD -332.835%
RedHill Biopharma Ltd. 20.97 Million USD -899.551%
Organogenesis Holdings Inc. 181.36 Million USD -15.618%
Guardion Health Sciences, Inc. 3.77 Million USD -5458.843%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -299.281%
Radius Health, Inc. 804.29 Million USD 73.929%
Universe Pharmaceuticals INC 13.75 Million USD -1424.516%
ProPhase Labs, Inc. 42.54 Million USD -392.871%
Phibro Animal Health Corporation 725.54 Million USD 71.099%
Procaps Group S.A. 462.06 Million USD 54.62%
Alvotech 1.88 Billion USD 88.862%
TherapeuticsMD, Inc. 14.02 Million USD -1395.414%
Viatris Inc. 27.21 Billion USD 99.23%
Rockwell Medical, Inc. 30.88 Million USD -578.994%
Aytu BioPharma, Inc. 90.37 Million USD -132.009%
SIGA Technologies, Inc. 57.97 Million USD -261.671%
Tilray Brands, Inc. 892.11 Million USD 76.496%
Lifecore Biomedical, Inc. 219.8 Million USD 4.601%
Shineco, Inc. 47.6 Million USD -340.503%
PetIQ, Inc. 645.22 Million USD 67.502%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -95424.163%
Incannex Healthcare Limited 5.83 Million USD -3496.69%
Neurocrine Biosciences, Inc. 1.01 Billion USD 79.43%
Alimera Sciences, Inc. 107.35 Million USD -95.323%
Silver Spike Investment Corp. 3 Million USD -6866.737%
Assertio Holdings, Inc. 148.41 Million USD -41.283%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -10959.645%
Petros Pharmaceuticals, Inc. 21.31 Million USD -883.718%
Clever Leaves Holdings Inc. 7.02 Million USD -2884.443%
Cyclo Therapeutics, Inc. 8.49 Million USD -2369.657%
Avadel Pharmaceuticals plc 173.38 Million USD -20.936%
Hempacco Co., Inc. 18.82 Million USD -1014.029%
Talphera, Inc. 6.29 Million USD -3233.657%
Alvotech 1.88 Billion USD 88.862%
Eagle Pharmaceuticals, Inc. 172.6 Million USD -21.487%
Lantheus Holdings, Inc. 835.25 Million USD 74.896%
Currenc Group, Inc. 177.67 Million USD -18.017%
Kamada Ltd. 109.96 Million USD -90.68%
Indivior PLC 1.95 Billion USD 89.254%
Evoke Pharma, Inc. 9.64 Million USD -2073.354%
Flora Growth Corp. 17.22 Million USD -1117.553%
Cyclo Therapeutics, Inc. 8.49 Million USD -2369.657%
HUTCHMED (China) Limited 536.38 Million USD 60.907%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 75.994%
Akanda Corp. 12.66 Million USD -1555.134%